Tumor hypoxia: Causative mechanisms, microregional heterogeneities, and the role of tissue-based hypoxia markers

Advances in Experimental Medicine and Biology

Volumn 923, Issue , 2016, Pages 77-86

  Vaupel, Peter ^a   Mayer, Arnulf ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Detection; Heterogeneities; Hypoxia markers; Malignant progression; Multiparametric immunohistochemistry; Subtypes; Tumor hypoxia

Indexed keywords

2 NITROIMIDAZOLE; BIOLOGICAL MARKER; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PIMONIDAZOLE; OXYGEN; TUMOR MARKER;

CLINICAL DECISION MAKING; CONFERENCE PAPER; HUMAN; HYPOXEMIA; HYPOXIA; MOLECULAR IMAGING; OXYGENATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SOLID TUMOR; TUMOR GROWTH; TUMOR VASCULARIZATION; ANIMAL; CELL PROLIFERATION; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; TUMOR HYPOXIA; TUMOR MICROENVIRONMENT; TUMOR VOLUME; VASCULARIZATION;

ANIMALS; BIOMARKERS, TUMOR; CELL PROLIFERATION; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OXYGEN; TUMOR BURDEN; TUMOR HYPOXIA; TUMOR MICROENVIRONMENT;

EID: 84984782771     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-38810-6_11     Document Type: Conference Paper

References (31)

1. Vaupel P (2004) Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol 14(3):198–206
2. Vaupel P (2008) Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis. Oncologist 13(Suppl 3):21–26
3. Vaupel P, Mayer A (2007) Hypoxia in cancer: signifi cance and impact on clinical outcome. Cancer Metastasis Rev 26(2):225–239
4. Vaupel P, Mayer A (2014) Hypoxia in tumors: pathogenesis-related classifi cation, characterization of hypoxia subtypes, and associated biological and clinical implications. Adv Exp Med Biol 812:19–24
5. Bayer C, Shi K, Astner ST et al (2011) Acute versus chronic hypoxia: why a simplifi ed classifi cation is simply not enough. Int J Radiat Oncol Biol Phys 80(4):965–968
6. Vaupel P, Mayer A (2014) Imaging tumor hypoxia: blood-borne delivery of imaging agents is fundamentally different in hypoxia subtypes. J Innov Opt Health Sci 07(02):1330005
7. 2histography. Antioxid Redox Signal 9(8):1221–1236
8. Epel B, Redler G, Halpern H (2014) How in vivo EPR measures and images oxygen. Adv Exp Med Biol 812:113–119
9. Swartz HM, Williams BB, Zaki BI et al (2014) Clinical EPR: unique opportunities and some challenges. Acad Radiol 21(2):197–206
10. Horsman MR, Mortensen LS, Petersen JB et al (2012) Imaging hypoxia to improve radiotherapy outcome. Nat Rev Clin Oncol 9(12):674–687
11. Ljungkvist AS, Bussink J, Kaanders JH et al (2007) Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers. Radiat Res 167(2):127–145
12. Kleiter MM, Thrall DE, Malarkey DE et al (2006) A comparison of oral and intravenous pimonidazole in canine tumors using intravenous CCI-103F as a control hypoxia marker. Int J Radiat Oncol Biol Phys 64(2):592–602
13. Ljungkvist AS, Bussink J, Kaanders JH et al (2006) Dynamics of hypoxia, proliferation and apoptosis after irradiation in a murine tumor model. Radiat Res 165(3):326–336
14. Yaromina A, Kroeber T, Meinzer A et al (2011) Exploratory study of the prognostic value of microenvironmental parameters during fractionated irradiation in human squamous cell carcinoma xenografts. Int J Radiat Oncol Biol Phys 80(4):1205–1213
15. Semenza GL, Wang GL (1992) A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12(12):5447–5454
16. 2tension. Am J Physiol 271(4 Pt 1): C1172–C1180
17. Jewell UR, Kvietikova I, Scheid A et al (2001) Induction of HIF-1α in response to hypoxia is instantaneous. FASEB J 15(7):1312–1314
18. Zhong H, De Marzo AM, Laughner E et al (1999) Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res 59(22):5830–5835
19. Talks KL, Turley H, Gatter KC et al (2000) The expression and distribution of the hypoxiainducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 157(2):411–421
20. Haugland HK, Vukovic V, Pintilie M et al (2002) Expression of hypoxia-inducible factor-1α in cervical carcinomas: correlation with tumor oxygenation. Int J Radiat Oncol Biol Phys 53(4):854–861
21. Zhong H, Mabjeesh N, Willard M et al (2002) Nuclear expression of hypoxia-inducible factor 1alpha protein is heterogeneous in human malignant cells under normoxic conditions. Cancer Lett 181(2):233–238
22. Dengler VL, Galbraith MD, Espinosa JM (2014) Transcriptional regulation by hypoxia inducible factors. Crit Rev Biochem Mol Biol 49(1):1–15
23. Mahon PC, Hirota K, Semenza GL (2001) FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 15(20):2675–2686
24. Airley R, Loncaster J, Davidson S et al (2001) Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin Cancer Res 7(4):928–934
25. Loncaster JA, Harris AL, Davidson SE et al (2001) Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 61(17):6394–6399
26. Mayer A, Wree A, Höckel M et al (2004) Lack of correlation between expression of HIF-1α protein and oxygenation status in identical tissue areas of squamous cell carcinomas of the uterine cervix. Cancer Res 64(16):5876–5881
27. Mayer A, Höckel M, Vaupel P (2005) Carbonic anhydrase IX expression and tumor oxygenation status do not correlate at the microregional level in locally advanced cancers of the uterine cervix. Clin Cancer Res 11(20):7220–7225
28. Mayer A, Höckel M, Wree A et al (2005) Microregional expression of glucose transporter-1 and oxygenation status: lack of correlation in locally advanced cervical cancers. Clin Cancer Res 11(7):2768–2773
29. Dellas K, Bache M, Pigorsch SU et al (2008) Prognostic impact of HIF-1α expression in patients with defi nitive radiotherapy for cervical cancer. Strahlenther Onkol 184(3):169–174
30. Mayer A, Höckel M, Wree A et al (2008) Lack of hypoxic response in uterine leiomyomas despite severe tissue hypoxia. Cancer Res 68(12):4719–4726
31. Mayer A, Vaupel P (2011) Hypoxia markers and their clinical relevance. In: Osinsky S, Friess H, Vaupel P (eds) Tumor hypoxia in the clinical setting. Akademperiodyka, Kiev, Ukraine, pp 187–202